INTRODUCTION
Influenza is among the most common human infectious diseases, every year affecting about 10-20% and in periods of pandemic even 40-50% of the world population, and is the cause of death of thousands of people around the world. The most at risk groups are the elderly or people with underlying chronic medical conditions, who have a high risk of developing complications. Influenza also causes huge economic losses by affecting the capacity of infected people to work. Few other infectious diseases exert such an adverse influence on public health and the economy worldwide as influenza (1) (2) (3) (4) (5) .
Influenza viruses are extremely variable, so the influenza vaccine must change in composition every year according to the influenza strains actually circulating in the population. The recent flu pandemic in 2009 and 2010 also highlighted the necessity for the national and global surveillance of influenza. In Slovakia, influenza surveillance is performed according to the recommendations of the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC), including the systematic collection of biological samples from sentinel sources. General practitioners and paediatricians from throughout Slovakia collect samples from patients with suspected influenza during the influenza season.
The gold diagnostic standard for diagnosing influenza virus infections is the traditional method of isolating the virus in cell cultures or chicken embryos. It is a technically demanding process, requiring significant financial and time investments. The success of laboratory diagnoses depends on the quality of laboratory equipment, the experience of the laboratory staff, the wide range of diagnostic methods as well as on the cooperation of physicians, epidemiologists and virologists (6) (7) (8) (9) (10) . Molecular biological methods (RT-PCR and real-time RT-PCR) have become an integral part of the virological surveillance of influenza, as was seen during the recent pandemic of influenza A/H1N1 (11) . Influenza viruses can also be detected by "near-patient" rapid tests with a time to obtain result of 15-30 minutes (10, (12) (13) (14) (15) . These tests were developed for the clinical purposes of causal influenza treatment, facilitating decisions on quarantine and the antibiotic therapy of infected patients as well as helping identify outbreaks within institutions. One disadvantage of these rapid tests, however, is the low sensitivity (12, (14) (15) (16) (17) .
Choosing the most appropriate diagnostic tool depends on the sensitivity and specificity of the tests, time to obtain results, repeatability, the simplicity of the procedure and costs (18) . However, the effectiveness of a particular diagnostic method in the direct diagnostics of influenza is also affected by various factors such as the age of the patient (19) (20) (21) , early sample collection and rapid transport to the laboratory (8, 22, 23) . The aim of our study was to assess the effect of patients' age and time to confirm influenza infection using four diagnostic methods (virus isolation, rapid test, RT-PCR, and real-time RT-PCR).
MATERIALS AND METHODS
Samples were collected during three types of influenza seasons: normal influenza seasons, pandemic influenza season and post-pandemic influenza season.
During four normal influenza seasons (2005-2009), samples of nasopharyngeal swabs and post-mortem material for direct diagnostics of influenza viruses were collected from districts in the Banská Bystrica and Žilina regions (central Slovakia). Clinical samples were taken by sentinel and non-sentinel physicians from patients with symptoms of influenza-like illness.
During the influenza pandemic (2009 and the influenza season 2009-2010), samples were collected from districts in the Banská Bystrica, Žilina, Košice, and Prešov regions (central and eastern Slovakia). This biological material was collected by sentinel and non-sentinel practitioners and also by physicians from various departments (infectology, pneumology, internal medicine, paediatrics). Samples from intensive care units, forensic and pathology workplaces (post-mortem material), and samples from patients diagnosed with Severe Acute Respiratory Infection (SARI) were also examined.
During one post-pandemic season (influenza season 2010-2011), samples were collected from districts in the regions of Banská Bystrica and Žilina (central Slovakia), also including samples from SARI patients and post-mortem material.
Samples were collected from both adult and paediatric patients. Nasopharyngeal swabs were collected and placed into containers with viral transport medium (Medium 199 with 0.5% BSA and antibiotics Penicillin G, Streptomycin and Amphotericin) (24) supplied by the laboratory. Samples were then delivered for analysis to the Regional Authority of Public Health Banská Bystrica, Division of Medical Microbiology, Departments of Medical Virology and Molecular Biology. We monitored the presence of influenza viruses by the virus isolation, rapid test and PCR based methods.
Virus Isolation
Virus isolations were carried out in accordance with standard virological techniques and the WHO protocol (24) . The process of virus isolation consists of the capture and multiplication of influenza viruses in MDCK cell cultures (Madin Darby Canine Kidney). The presence of influenza viruses manifests as a cytopathic effect, observed under a light microscope. A haemagglutination test in microplates was also performed to demonstrate the presence of influenza viruses. A haemagglutination test with three kinds of red blood cells (chicken, guinea pig and human type 0) was performed with harvested fluids. In case of a positive haemagglutination, the sample was subjected to further analysis to distinguish between influenza virus A, B or the pandemic influenza virus A/H1N1 using RT-PCR or real-time RT-PCR methods. Inoculated cell cultures were passaged at least three times before a sample was considered negative.
Rapid Test
Directigen EZ Flu A+B is a rapid commercial chromatographic immunoassay test for the direct and qualitative detection of influenza viruses A and B from nasopharyngeal swabs and other materials from symptomatic patients. Viral antigens of influenza A and B can be distinguished from each other using a single processed sample with time to result of 15 min. A positive test result was considered indicative of the presence of influenza A or B virus antigens. A negative test result was considered as probably negative for the presence of influenza virus antigens A and B, respectively.
RT-PCR
We used a conventional qualitative RT-PCR method to detect influenza RNA in samples of biological material. The diagnostic kit Amplisens® RNA PCR TEST Influenza A + B Interlabservice (Ukraine) was used according to the manufacturer's protocol. After amplification, the PCR products were detected by electrophoresis in an agarose gel under UV light. The results of RT-PCR were considered positive or negative depending on the presence or absence, respectively, of an amplification product as detected by electrophoresis.
Real-time RT-PCR
The CDC Real-time RT-PCR (rRT-PCR) protocol was used for the real-time RT-PCR detection of pandemic A/H1N1 influenza virus. This protocol includes a panel of primer pairs and duallabelled hydrolysis (Taqman®) probes for the in vitro qualitative detection and characterization of pandemic influenza viruses in respiratory specimens. The InfA primer and probe set was designed for the universal detection of type A influenza viruses. The swInfA primer and probe set was designed to specifically detect all swine influenza A viruses. The swH1 primer and probe set was designed to specifically detect swine H1 influenza viruses. Each sample RNA extract was tested by each of the three primer/ probe sets described above plus the RNase P gene to serve as an internal positive control for human nucleic acid. At the same time and under the same conditions, the real-time RT-PCR procedure was controlled using positive and negative controls.
The results were evaluated qualitatively, with a sample considered positive when the fluorescence curves increased during the amplification suggesting the presence of target cDNA. The results were validated using positive control samples.
Data Analysis
Influenza detection data obtained by the four different methods (virus isolation, rapid test, RT-PCR, and real-time RT-PCR) were analyzed using Generalized Linear Models (GLM) (25) . GLM with binomial error distribution and the logit link function (logistic regression) were employed in order to test the effect of patients' age (AGE), time from the onset of influenza illness to sample collection (T1) and time from the sample collection to delivery of samples to the laboratory (T2) on the probability of influenza virus detection. Second order interaction terms (AGE × T1 and AGE × T2) were also included into the modelling to account for possible multiplicative effects on the probability of detection. Only samples with T1 ≤ 15 days were included in the analysis, since the remaining 4.7% of observations with T1 longer than 15 days appeared as severe outliers in the models. Initially, full models were fitted to the data, including all explanatory variables and two-way interactions. To acquire minimal adequate models, the full models were simplified following backward stepwise deletion (26) . Starting from the higher-order terms, significance was tested using likelihood-ratio χ 2 tests to compare the change in model deviance after deleting each term. Separate models were built for each combination of detection method and type of influenza season. Diagnostic plots of residuals were employed to check the performance of the final models. In order to facilitate interpretation of the results, relative changes in odds ratios (OR) were calculated and associated 95% confidence limits (CL) were obtained using 1000 non-parametric bootstrap re-samples (27) . The fit of the final models was assessed using McFadden's (pseudo) determination coefficient (R2MF) (28) . All analyses were performed in the R language (29) . The effects of patients' age (AGE), and times to sample collection (T1) and delivery (T2) on the probability of influenza virus detection was examined using logistic regression. Final regression models for each combination of method and type of influenza season are given in Table 1 . Time from sample collection to delivery (T2) did not play a role in the detection of influenza. In contrast, T1 and AGE showed significant relationships with the probability of detecting influenza for each combination of method and season, with the exception of real-time RT-PCR during the post-pandemic season. Generally, the probability of detecting influenza decreased with time from the onset of illness to sample collection as well as with patients' age ( Fig. 1) . Depending on the method and season, the odds of detecting influenza decreased, in a range from 7.5 to 31.8%, with each day from the onset of illness to sample collection. As judged by odds ratios, the strength of the effect of T1 on particular methods was, in descending order, virus isolation, RT-PCR, rapid test and real-time RT-PCR. The significant effect of patients' age was found only during the normal and post-pandemic seasons. The odds detecting influenza decreased, in a range from 1.1 to 3.0%, with every year of patient's age. Again, the rapid test and virus isolation were more sensitive to patients' age than PCR methods. The effects of T1 and AGE were independent of each other since the interaction terms were non-significant. A common feature of all models was the low explanatory power, i.e. explained deviance ranged from 2.1 to 8.2% as expressed by R2MF. An exact comparison of the sensitivity of these various methods cannot be conclusively performed on the basis of our results because we did not apply all methods on the same samples. However, some reasonable inferences can be made from the patterns in our findings. Among the methods compared here, PCR-based methods appear to be the most sensitive for the detection of influenza viruses, as expected. This is true for both RT-PCR and especially for real-time RT-PCR, which was used to identify and subtype pandemic influenza A/H1N1 during the pandemic and the post-pandemic periods. Real-time RT-PCR was used mainly to test samples positive by RT-PCR. A few samples tested by real-time RT-PCR consisted of material from patients with severe respiratory symptoms, since there was not enough time to perform RT-PCR.
RESULTS

Altogether
DISCUSSION
The rapid test method (Directigen EZ Flu A + B) appears to be least sensitive, although it was used to test samples from patients with SARI, which have a higher probability of being positive. A negative test result does not eliminate the possibility of an influenza infection, so it is necessary to evaluate the patient's clinical symptoms with regard to the epidemiological situation. Results of this test need to be confirmed by virus isolation and/or PCR methods (10, (15) (16) (17) 30) .
Time from onset of illness to sample collection (T1) showed a significant effect on the detection of influenza using all but one method (real-time RT-PCR). However, it should be again emphasised that real-time RT-PCR was used mainly for subtyping and more precise identification of influenza-A positive samples detected by RT-PCR.
Virus isolation (MDCK) appeared to be the most sensitive method to changes in T1. The odds of detecting influenza decreased by 23.5% (normal seasons) or even by 31.8% (postpandemic season) with every successive day from the onset of illness. The yield of positive samples can be enhanced when swabs are taken early (24-48 hours) after the disease onset. This reflects the pattern of virus shedding (8) . Samples which can be detected as positive must contain a sufficient number of viable viral particles capable of replication (6, 8, 10, 23, 24) , making it difficult or even impossible to isolate influenza viruses from samples taken at later stages of the disease.
The rapid test method also showed high sensitivity to T1. For a one-day change in T1 there was a 16.7% decrease in the odds of detecting influenza. This could be explained by the generally lower sensitivity of this test (10, 12, 15, 31, 32) . Samples which can be detected as positive must contain a relatively large number of virus particles (not necessarily viable) (12, 17, 24, 30, 32) . Also, the manufacturer of the test (Directigen) recommends only using swabs obtained within 48 hours after the onset of clinical symptoms. This limitation has been confirmed by several studies (9, 10, 14, 22, 33) .
PCR methods are able to identify viruses in samples with a lower concentration of viral particles and which do not need to be viable. For this reason PCR is a more sensitive technique than the other methods used. This increases the possibility of detecting influenza viruses also in samples taken in the later stages of the disease (34) (35) (36) (37) (38) .
On the contrary, time from sample collection to delivery (T2) did not play a role in the probability of influenza detection in our study. Undoubtedly, proper collection and transport of samples increases the probability of a successful result (6, 24, 30) . In general, cool holding temperatures (not freezing), short transport time (optimally 1-2 days, max. 3-4 days after sampling), and high virus concentrations are important for diagnosis. However, influenza viruses can be successfully detected in the samples transported at ambient temperatures and analysed several days after the sampling (8, 23) .
Age showed significant relationships with the probability of detecting influenza for each combination of method and season, with the exception of real-time RT-PCR during the post-pandemic season. These results again reflect the limits of particular diagnostic methods to detect the number of viral particles in a sample. The probability of detecting influenza decreased with patients' age. Generally, the highest morbidity is in preschool and schoolage children (1, 3, 39) . Moreover, virus shedding is significantly higher and lasts for a longer period in children than in adults (21) . Possible explanation is immature immune system of children and low previous exposition to influenza virus, which implicates a lower level of immunity against influenza (1, 20, 21, 39) .
The generally low fit of the models (explained deviance < 10%) could be caused by various external factors that affect the outcome of these tests and that were not included in our models. This includes mainly the technique of sample collection, and the prevalence or incidence of influenza in the population, according to the strict clinical case definition of influenza and influenza-like illness by physicians (8) . The immunological status of the patient and previous use of antivirals are also factors that may affect the success of influenza laboratory diagnosis (1, 19, 21, 39) .
Laboratory results based on virus isolation are usually not available in less than 3-5 days, sometimes up to 10 days (especially in the case of negative results) (7, 11, 40, 41) . The time to result of the rapid test is 15 minutes, but there is a high probability of false negative results (10, 15, 30, 32) . The advantages of PCR methods are the short time to results (4-5 hours) and high sensitivity of the tests (17, 34, 36, 38) . However, the high cost and necessity of special laboratory equipment and trained staff are disadvantages (34, 36, 37) . Virus isolation is the only method by which is possible to obtain viable flu virus strains. This can be especially useful since isolates can be subtyped, antigenic and genetic characterized, used for the production of vaccines or for monitoring of antiviral drugs sensitivity (2, 16, 24, 30, 41) . This method is also essential for the diagnosis of new and unexpected infections (7, 18, 37, 40) . However, virus isolation methods are very sensitive to the time of sample collection and its quality (40, 42, 43) .
CONCLUSION
The introduction of molecular-biological methods (RT-PCR and real-time RT-PCR) and rapid screening tests in diagnostic practice has significantly accelerated and improved the diagnosis of influenza. Rapid detection is important not only for the treatment of individual patients, but also for public health and for defining and managing outbreaks of influenza in the population. However, viral isolation in cell cultures still remains an integral and irreplaceable part of influenza surveillance (43) . Rapid and accurate diagnosis of influenza allows the early initiation of antiviral therapy and prophylaxis, limiting antibiotic therapy and other tests, and allows the implementation of appropriate infection control strategies for individuals and public health issues (10, 30, 42) . Laboratories which participate in influenza surveillance should use several methods to enable rapid and accurate influenza virus detection, and to provide a useful tool for public health institutions in the management and surveillance of influenza and influenza-like illness (1, 8, 10, 30, 37) .
